Orexo: Zubsolv Rx data

Research Update

2019-11-08

15:49

The Zubsolv market share was unchanged in October, amounting to 4.5% (quantity). This development was in/line with our expectations.

KP

Klas Palin

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.